Collectively, this unexpected inverse relationship between IGF2BP1 and pSTAT3 provides new insights into EC biology and suggests that IGF2BP1 may modulate tumor progression not solely through classical oncogenic mRNA stabilization, but also via suppression of key inflammatory and pro-survival signaling pathways such as STAT328-33. The gene discussed is IGF2BP1; the disease is neoplasm.